Issuances | Health Technology Assessment Division

Preliminary Recommendation for the Inclusion of Potassium Citrate 1620 mg (15 mEq) Tablet in the PNF

Posted on April 13, 2022

Document link: HTAC Preliminary Recommendation of Potassium Citrate 15mEq Tablet (Proponents may submit appeals to hta@doh.gov.ph until 27 April 2022.) Document Preview:

[Department Personnel Order No. 2022- 1102] Authority for Select Department of Health (DOH) Personnel to conduct a Hybrid Workshop on the Development of Guidelines in the Creation of the Philippine Essential Medical Device List (PEMDL) on April 22, 2022 in Metro Manila,

Posted on April 7, 2022

[Department Circular No. 2022- 0183] Opening of the 2022 Call for topic nomination

Posted on April 1, 2022

[Department Circular No. 2022- 0164] Health Technology Assessment Council (HTAC) Recommendation for reinclusion of vasopressin 20 iU/ml (IM/IV) in the Philippine National Formulary

Posted on March 23, 2022

Preliminary Recommendation for the Inclusion of Rituximab 1400 mg/11.7 mL Solution for Subcutaneous (SC) Injection for the Treatment of Non-Hodgkin’s Lymphoma

Posted on March 4, 2022

Document link: Evidence Summary on Subcutaneous Rituximab for the Treatment of Non-Hodgkin’s Lymphoma (Proponents may submit appeals to hta@doh.gov.ph until 18 March 2022.) Document Preview: